CClinicalTrials.gg
TerminatedNCT00849940Updated Feb 9, 2017Results posted

Validation of Brain Oxygenation Monitor on Pediatric Patients

An interventional study of CAS NIRS FORE-SIGHT oximeter in Cardiac Catheterization, sponsored by Duke University. Terminated at 1 site in United States. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2017-02-09.

Sponsored by Duke University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Not applicable
Ages
Up to 17 Years
Sex
All
01

Study summary

The aim of this study is calibrate (adjust and tune) the CAS FORE-SIGHT Near-Infrared Spectroscopy (NIRS) monitor when used to measure the tissue oxygen saturation of internal organs (StO2). This is a measure of the amount of oxygen carried by the blood within the internal organs. In addition the study will assess the degree of similarities between StO2 and mean mixed venous oxygen saturation - a measure of the amount of oxygen carried in the blood returning to the heart.

Read the detailed description

NIRS cerebral oximeters are FDA-approved devices used to measure oxygen saturation within the brain, in a similar manner to pulse oximeters that measure the oxygen saturation in the finger tip. The sensor pads are placed on the surface of the forehead and shine near-infrared light through the skull and brain tissue from which the brain tissue oxygen saturation is estimated. The same principles can be applied when the sensor pads are placed over the internal organs of the abdomen, for example, the liver. Currently the only way to accurately measure the oxygen saturation of internal organs is by the invasive placement of intravenous lines into the blood vessels of that organ. This study will determine if the NIRS sensors can reliably estimate the tissue oxygen saturation non-invasively by placing the pad over the skin of the abdomen.

The study will be conducted in pediatric patients who are undergoing cardiac catheterization, a procedure in which invasive lines are placed in order to get information about the heart. The procedure is always conducted under general anesthesia. During the cardiac catheterization procedure blood samples are routinely taken for oxygen saturation analysis. In the study two oximeter sensor pads will be placed on the forehead (one on each side) and two further oximeter sensor pads will be placed on the abdominal wall. The oxygen saturation values from all oximeter sensors will be recorded continuously throughout the cardiac catheterization procedure and will be compared to the oxygen saturation values from the blood samples. In addition to the routine blood samples taken as part of the cardiac catheterization, one blood sample will be taken when the invasive line is within the right hepatic (liver) vein.

The information from this study will determine how well the oximeter sensors estimate the oxygen saturation of both the internal organs (StO2) and the blood returning to the heart (mean mixed venous oxygen saturation).

02

Conditions studied

  • Cardiac Catheterization

Keywords

  • Spectroscopy
  • Near infrared
  • Oximetry
  • Hypoxemia
  • Tissue oxygenation
  • Pediatric
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ≤ 18 years old
  • ≥ 2.5 kg and ≤ 40 kg weight
  • Undergoing cardiac catheterization at Duke pediatric cardiac catheterization laboratory

Exclusion criteria

Exclusion Criteria:

  • Known structural neurologic or craniofacial disease
  • Arterial catheter placement not part of planned catheterization procedure
  • Anemia (hemoglobin \< 10 g/dl)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    CAS NIRS FORE-SIGHT oximeter

    Pediatric patients presenting for cardiac catheterization.

    Device: CAS NIRS FORE-SIGHT oximeter

Interventions

  • DeviceCAS NIRS FORE-SIGHT oximeter

    Comparison of non-invasive tissue oxygen saturation with blood sample-derived (calculated) tissue oxygen saturation.

06

What researchers measure

Primary outcomes

  1. Accuracy of NIRS Sensor to Estimate Flank Tissue Oxygen Saturation

    The flank tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of flank tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the flank tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other. oxygen saturation when measured displayed NIRS value of the tissue sensor placed over the flank to a reference CO-oximetry model, reported as bias and precision. The model is weighted as 30:70 arterial: central venous oxygen saturation when measured by blood gas co-oximetry.

    Time frame: Data collected from individual participants over 4 hour timeframe.

  2. Accuracy of NIRS Sensor to Estimate Intestine Tissue Oxygen Saturation

    The intestine tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of intestine tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the intestine tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other.

    Time frame: Data collected from individual participants over 4 hour timeframe.

  3. Accuracy of NIRS Sensor to Estimate Hepatic Tissue Oxygen Saturation

    The hepatic tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of hepatic tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the hepatic tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other.

    Time frame: Data collected from individual participants over 4 hour timeframe.

Secondary outcomes

  1. Correlation Between Somatic StO2 and Cerebral SctO2 Oxygen Saturation

    Time frame: Data collected from individual participants over 4 hour timeframe

  2. Correlation Between NIRS Derived Estimate of Hemoglobin Concentration and Measured Arterial Blood Hemoglobin Concentration.

    Time frame: Data collected from individual participants over 4 hour timeframe

07

Results

Posted Mar 28, 2016
Limitations and caveats
Blood samples collected from pediatric patients undergoing cardiac catheterization. Venous blood samples taken from within IVC as close to the tissue of interest.

Participant flow

Participant flow — Overall Study
MilestoneCAS NIRS FORE-SIGHT Oximeter
Started72
Completed68
Not completed4
Withdrew: Physician decision4

Outcome measures

PrimaryAccuracy of NIRS Sensor to Estimate Flank Tissue Oxygen Saturation

The flank tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of flank tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the flank tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other. oxygen saturation when measured displayed NIRS value of the tissue sensor placed over the flank to a reference CO-oximetry model, reported as bias and precision. The model is weighted as 30:70 arterial: central venous oxygen saturation when measured by blood gas co-oximetry.

Time frame:
Data collected from individual participants over 4 hour timeframe.
Reported as:
Mean · percentage of oxygen saturation
Accuracy of NIRS Sensor to Estimate Flank Tissue Oxygen Saturation
percentage of oxygen saturationCAS NIRS FORE-SIGHT Oximeter
Accuracy of NIRS Sensor to Estimate Flank Tissue Oxygen Saturation-0.67 ± 4.88
PrimaryAccuracy of NIRS Sensor to Estimate Intestine Tissue Oxygen Saturation

The intestine tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of intestine tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the intestine tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other.

Time frame:
Data collected from individual participants over 4 hour timeframe.
Reported as:
Mean · percentage of oxygen saturation
Accuracy of NIRS Sensor to Estimate Intestine Tissue Oxygen Saturation
percentage of oxygen saturationCAS NIRS FORE-SIGHT Oximeter
Accuracy of NIRS Sensor to Estimate Intestine Tissue Oxygen Saturation1.57 ± 4.41
PrimaryAccuracy of NIRS Sensor to Estimate Hepatic Tissue Oxygen Saturation

The hepatic tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of hepatic tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the hepatic tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other.

Time frame:
Data collected from individual participants over 4 hour timeframe.
Reported as:
Mean · percentage of oxygen saturation
Accuracy of NIRS Sensor to Estimate Hepatic Tissue Oxygen Saturation
percentage of oxygen saturationCAS NIRS FORE-SIGHT Oximeter
Accuracy of NIRS Sensor to Estimate Hepatic Tissue Oxygen Saturation0.04 ± 5.63
SecondaryCorrelation Between Somatic StO2 and Cerebral SctO2 Oxygen Saturation
Time frame:
Data collected from individual participants over 4 hour timeframe

No measurements were reported for this outcome.

SecondaryCorrelation Between NIRS Derived Estimate of Hemoglobin Concentration and Measured Arterial Blood Hemoglobin Concentration.
Time frame:
Data collected from individual participants over 4 hour timeframe

No measurements were reported for this outcome.

Adverse events

Collected over 2 years. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
CAS NIRS FORE-SIGHT Oximeter—0/72 (0%)0/72 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)CAS NIRS FORE-SIGHT Oximeter
<=18 years72
Between 18 and 65 years0
>=65 years0
Gender
Gender(Participants)CAS NIRS FORE-SIGHT Oximeter
Female34
Male38
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)CAS NIRS FORE-SIGHT Oximeter
Hispanic or Latino0
Not Hispanic or Latino66
Unknown or Not Reported6
Region of Enrollment
Region of Enrollment(participants)CAS NIRS FORE-SIGHT Oximeter
United States72
08

Study locations

1 site
  • Duke University Health System
    Durham, North Carolina 27710, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00849940
Lead sponsor
Duke University
Collaborators
CAS Medical Systems, Inc.
Responsible party
Sponsor
First posted
Feb 24, 2009
Start date
Feb 2009
Primary completion
Nov 2014
Completion
Nov 2014
Results posted
Mar 28, 2016
Last update
Feb 9, 2017

Study contacts

David B MacLeod, FCRA
principal investigator · Duke Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion